0001562180-22-003739.txt : 20220504
0001562180-22-003739.hdr.sgml : 20220504
20220504163302
ACCESSION NUMBER: 0001562180-22-003739
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220502
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hykes Andrew
CENTRAL INDEX KEY: 0001806431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 22892048
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-05-02
false
0001531048
Inari Medical, Inc.
NARI
0001806431
Hykes Andrew
C/O INARI MEDICAL, INC.
6001 OAK CANYON, SUITE 100
IRVINE
CA
92618
false
true
false
false
Chief Operating Officer
Common Stock
2022-05-02
4
S
false
200.00
77.14
D
155366.00
D
Common Stock
2022-05-02
4
S
false
1418.00
78.76
D
155566.00
D
Common Stock
2022-05-02
4
S
false
2119.00
79.80
D
153247.00
D
Common Stock
2022-05-02
4
S
false
1163.00
80.80
D
152084.00
D
Common Stock
2022-05-02
4
S
false
100.00
81.75
D
151984.00
D
Common Stock
1550.00
I
By Child 1
Common Stock
1550.00
I
By Child 2
Common Stock
1550.00
I
By Child 3
Common Stock
1000.00
I
By Spouse
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
This transaction was executed in multiple trades at prices ranging from $77.11 to $77.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $78.36 to $79.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $79.36 to $80.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $80.43 to $81.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Angela Ahmad, attorney-in-fact for
2022-05-04